Clinical Trial Update: A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity [Phase 1]

View source ↗

Summary

A two-part Phase 1b trial is evaluating the safety, pharmacokinetics, and preliminary efficacy of CRB-913 in obese participants who are otherwise healthy; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CRB-913

Snippet

Sponsor: Corbus Pharmaceuticals Inc. | Conditions: Obese But Otherwise Healthy Participants | Phase 1 | Status: RECRUITING